A more recent study indicated that an increased ZHX1 expression was associated with a better or worse prognosis for patients with gastric cancer in the clinical stages, including lymph node metastasis or distant metastasis, and surgical therapy [31]. Here, ZHX1 is linked to gastric cancer.